- NS-398
-
- $44.00 / 5mg
-
2026-01-16
- CAS:123653-11-2
- Min. Order:
- Purity: 99.00%
- Supply Ability: 10g
- NS-398
-
- $30.00 / 1KG
-
2025-06-27
- CAS:123653-11-2
- Min. Order: 50KG
- Purity: 99%
- Supply Ability: 500000kg
- NS-398
-
- $20.00 / 1kg
-
2025-06-20
- CAS:123653-11-2
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 10 tons
|
| | NS-398 Chemical Properties |
| Melting point | 124-126 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3)) | | Boiling point | 490.6±55.0 °C(Predicted) | | density | 1.377±0.06 g/cm3(Predicted) | | RTECS | PB0473500 | | storage temp. | Sealed in dry,Room Temperature | | solubility | DMSO: >5 mg/mL | | form | solid | | pka | 6.33±0.10(Predicted) | | color | off-white | | InChI | 1S/C13H18N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h7-9,11,14H,2-6H2,1H3 | | InChIKey | KTDZCOWXCWUPEO-UHFFFAOYSA-N | | SMILES | CS(=O)(=O)Nc1ccc(cc1OC2CCCCC2)[N+]([O-])=O |
| Safety Statements | 22-24/25 | | WGK Germany | 3 | | HS Code | 2935.90.9500 | | Storage Class | 11 - Combustible Solids |
| | NS-398 Usage And Synthesis |
| Description | NS-398 is a selective inhibitor of cyclooxygenase-2 (COX-2). The IC50 values for human recombinant COX-1 and -2 are 75 and 1.77 μM, respectively. The IC50 values for ovine COX-1 and -2 are 220 and 0.15 μM, respectively. | | Uses | NS-398 is a selective Cox-2 inhibitor neuroprotective agent. | | Definition | ChEBI: A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2. | | Biological Activity | Selective cyclooxygenase-2 inhibitor (IC 50 values are 3.8 and > 100 μ M for COX-2 and COX-1 respectively). Induces apoptosis in colorectal tumor cells and elevates COX-2 protein expression in vitro . Orally active and non-ulcerogenic analgesic and anti-inflammatory in vivo . | | storage | Store at RT | | references | [1]. futaki n, takahashi s, yokoyama m, et al. ns-398, a new anti-inflammatory agent, selectively inhibits prostaglandin g/h synthase/cyclooxygenase (cox-2) activity in vitro. prostaglandins, 1994, 47(1): 55-59. [2]. elder dj, halton de, crew te, et al. apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug ns-398. int j cancer, 2000, 86(4): 553-560. [3]. mack strong ve, mackrell pj, concannon em, et al. ns-398 treatment after trauma modifies nf-kappab activation and improves survival. j surg res, 2001, 98(1): 40-46. |
| | NS-398 Preparation Products And Raw materials |
|